PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery

NCT07023094 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Hip Disease
Hip Dysplasia
Hip Arthropathy

Interventions

DRUG: Ropivacaine 0.2% for PENG Block
DRUG: Ropivacaine 0.2% for LFCB
DRUG: Ropivacaine 0.2% for L-ESPB
DRUG: Ropivacaine 0.2% for S-ESPB

Sponsor

Poznan University of Medical Sciences